Such relationship was also observed in renal cell carcinoma (RCC) patient samples, where the PD‐L1 decreases with the induction of GZMB+CD8+ T cell after the patients received Sunitinib treatment (Figure 2K–L). The gene discussed is CD8A; the disease is hereditary clear cell renal cell carcinoma.